These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 157281)

  • 1. Further studies on the role of cholinergic mechanisms in the development of increased naloxone potency in mice.
    Wong CL; Bentley GA
    Eur J Pharmacol; 1979 Jun; 56(1-2):115-21. PubMed ID: 157281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the cholinergic system in the development of increased naloxone potency in mice.
    Wong CL; Bentley GA
    Eur J Pharmacol; 1978 Aug; 50(3):221-30. PubMed ID: 567586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of cholinergic compounds on the development of morphine tolerance, dependence and increased naloxone potency in mice.
    Wong CL; Bentley GA
    Eur J Pharmacol; 1980 Jan; 61(2):99-109. PubMed ID: 7188753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of muscarinic cholinergic involvement in the antinociceptive effects of morphine and clonidine in the mouse.
    Lipman JJ; Spencer PS
    Eur J Pharmacol; 1980 Jun; 64(4):249-58. PubMed ID: 7389822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine tolerance and physical dependence: influence of cholinergic agonists and antagonists.
    Bhargava HN; Way EL
    Eur J Pharmacol; 1976 Mar; 36(1):79-88. PubMed ID: 944135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.
    Shen KF; Crain SM
    Brain Res; 1997 May; 757(2):176-90. PubMed ID: 9200746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased antagonist potency of naloxone caused by morphine pretreatment in mice.
    Wong CL; Bentley CA
    Eur J Pharmacol; 1978 Feb; 47(4):415-22. PubMed ID: 564774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiate dependence following acute injections of morphine and naloxone: the assessment of various withdrawal signs.
    Ritzmann RF
    Pharmacol Biochem Behav; 1981 Apr; 14(4):575-7. PubMed ID: 7195040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of aspirin and paracetamol on the increased naloxone potency induced by morphine pretreatment.
    Wong CL; Wai MK; Roberts MB
    Eur J Pharmacol; 1980 Oct; 67(2-3):241-6. PubMed ID: 7461031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The involvement of histamine receptors in morphine-induced increased naloxone potency in mice.
    Wong CL
    Methods Find Exp Clin Pharmacol; 1985 Feb; 7(2):69-74. PubMed ID: 3990446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary studies on increased naloxone potency and its relationship to morphine tolerance and dependence in mice.
    Wong CL; Wai MK; Roberts MB
    Clin Exp Pharmacol Physiol; 1980; 7(3):305-10. PubMed ID: 7190475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cholinergic systems in the expression of morphine withdrawal.
    Sharif SI; el-Kadi AO
    Neurosci Res; 1996 Jun; 25(2):155-60. PubMed ID: 8829152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of chlorpromazine pretreatment on morphine analgesia and naloxone potency in adrenalectomized mice.
    Wong CL; Wai MK
    Clin Exp Pharmacol Physiol; 1982; 9(6):595-601. PubMed ID: 7166003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic modification of naloxone-induced jumping in morphine dependent mice.
    Brase DA; Tseng LF; Loh HH; Way EL
    Eur J Pharmacol; 1974 Apr; 26(1):1-8. PubMed ID: 4857603
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of chlorpromazine pretreatment on the narcotic antagonistic potency of naloxone in mice.
    Wong CL; Wai MK; Roberts MB
    Clin Exp Pharmacol Physiol; 1982; 9(1):69-75. PubMed ID: 7094435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased naloxone potency induced by pretreatment with morphine and nalbuphine in mice.
    Wong CL; Wai MK
    Clin Exp Pharmacol Physiol; 1984; 11(3):301-7. PubMed ID: 6744688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of physical dependence in mice by naloxone-precipitated jumping after a single dose of morphine.
    Smits SE
    Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):651-61. PubMed ID: 1171511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine inhibits dopaminergic and cholinergic induced ejaculation in rats.
    Zarrindast MR; Mamanpush SM; Rashidy-Pour A
    Gen Pharmacol; 1994 Jul; 25(4):803-8. PubMed ID: 7958745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective potentiation by ouabain of naloxone-induced withdrawal contractions of isolated guinea-pig ileum following acute exposure to morphine.
    Mundey MK; Mason R; Wilson VG
    Br J Pharmacol; 1998 Jul; 124(5):911-6. PubMed ID: 9692776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.